EMEA-002153-PIP01-17-M01
Key facts
Invented name |
|
Active substance |
|
Therapeutic area |
Pneumology-allergology
|
Decision number |
P/0058/2020
|
PIP number |
EMEA-002153-PIP01-17-M01
|
Pharmaceutical form(s) |
Inhalation powder, pre-dispensed
|
Condition(s) / indication(s) |
Treatment of asthma
|
Route(s) of administration |
Inhalation use
|
Contact for public enquiries |
GlaxoSmithKline Trading Services Limited
Tel. +1 4388998201 |
Decision type |
RPM: decision refers to a refusal on the application for modification of an agreed PIP
|